Top 5 CRISPR Stocks To Invest In - Insider Monkey
Exact Sciences Corporation (NASDAQ:EXAS) specializes in cancer screening and diagnostic test products, operating both in the United States and internationally.
Source: insidermonkey.com
Page 27 - Exact Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Exact Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Exact Sciences Today - Breaking & Trending Today
Exact Sciences Co. (NASDAQ:EXAS) Shares Acquired by Biondo Investment Advisors LLC
Biondo Investment Advisors LLC increased its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 2.8% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 112,696 shares of the medical research company’s stock after buying an additional 3,103 shares […]
Source: dailypolitical.com
Biondo Investment Advisors LLC Purchases 3,103 Shares of Exact Sciences Co. (NASDAQ:EXAS)
Biondo Investment Advisors LLC boosted its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 2.8% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 112,696 shares of the medical research company’s stock after buying an additional 3,103 shares during the […]
Source: tickerreport.com
Van ECK Associates Corp Decreases Holdings in Exact Sciences Co. (NASDAQ:EXAS)
Van ECK Associates Corp lowered its holdings in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 9.9% during the third quarter, HoldingsChannel.com reports. The fund owned 149,468 shares of the medical research company’s stock after selling 16,345 shares during the period. Van ECK Associates Corp’s holdings in Exact Sciences were worth $10,197,000 as of its […]
Source: wkrb13.com
Swiss National Bank Sells 63,200 Shares of Exact Sciences Co. (NASDAQ:EXAS)
Swiss National Bank trimmed its position in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 9.8% during the third quarter, HoldingsChannel.com reports. The fund owned 580,280 shares of the medical research company’s stock after selling 63,200 shares during the quarter. Swiss National Bank’s holdings in Exact Sciences were worth $39,587,000 at the end of the […]
Source: dailypolitical.com